Yingying Lu

Yingying Lu

Auto-generated profile, based on publicly available information

Yingying Lu

Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2022 in Physiological Genomics
Verified
Journal Article
Closed access
PDF file
YLYingying Lu
Yingying Lu
LALingling An
Lingling An
MTMatthew R. G. Taylor
Matthew R. G. Taylor
Qin ChenQin Chen
Qin Chen
Increased levels of oxidative stress have been found with heart failure. Whether failing hearts express antioxidant and detoxification enzymes have not been addressed systematically. Nrf2 gene encodes a transcription factor that regulates the expression of antioxidant and detoxification genes. Using RNA-Seq data set from explanted hearts of 37 patients with dilated cardiomyopathy (DCM), 13 patients with ischemic cardiomyopathy (ICM), and 14 nonfailure (NF) donors as a control, we addressed whether failing hearts change the expression of Nrf2, its negative regulator Keap1, and antioxidant or detoxification genes. Significant increases in the ratio of Nrf2 to Keap1 were found to associate with DCM or ICM. Antioxidant genes showed decreased expression in both types of heart failure, including NQO1, SOD1, GPX3, GPX4, GSR, PRDX1, and TXNRD1. Detoxification enzymes, GCLM and EPHX1, also showed decreased expression, whereas the CYP1B1 transcript was elevated in both DCM and ICM. The genes encoding metal-binding protein ferritin were decreased, whereas five out of 12 metallothionein genes showed elevated expression. Our finding on Nrf2 gene expression has been validated by meta-analysis of seven independent data sets of microarray or RNA-Seq for differential gene expression in DCM and ICM from NF controls. In conclusion, minor elevation of Nrf2 gene expression is not coupled to increases in antioxidant and detoxification genes, supporting an impairment of Nrf2 signaling in patients with heart failure. Decreases in multiple antioxidant and detoxification genes are consistent with the observed increases of oxidative stress in failing hearts.

1 March 2020 in Annals of Translational Medicine
Verified
Journal Article
Open access
PDF file
YLYingying Lu
Yingying Lu
Hong Sheng JiangHong Sheng Jiang
Hong Sheng Jiang
BLBingjue Li
Bingjue Li
LCLuxi Cao
Luxi Cao
QSQixia Shen
Qixia Shen
JCJianghua Chen
Jianghua Chen
Background: Small vessel vasculitis (SVV) is a group of systemic autoimmune diseases that are mediated by neutrophil extracellular traps (NETs) in response to cathelicidin LL37, an aging molecular marker, which could be induced by telomere dysfunction. Therefore, in this study, we evaluated the hypothesis that telomere dysfunction in neutrophils may promote SVV via an LL37-NETs-dependent mechanism. Methods: We contrasted the release of neutrophil NETs from mice with telomere dysfunction, mice with DNA damage and wide-type mice. Neutrophil telomere length, the expression of LL37, and the formation of NETs were measured in SVV patients and healthy controls (HCs). The co-expression of γH2AX, LL37, and NETs were detected in SVV patients to evaluate the association of the immune aging of neutrophils and pro-inflammatory conditions. LL37 inhibitor was used to verify its key role in NETs release in SVV patients and DNA damage mice. Results: We found that NETs were over-induced by telomere dysfunction and DNA damage in mice, which may be associated with a marked increase in LL37. For patients with SVV, telomeres in neutrophils were significantly shortened, which was also associated with higher levels of LL37 and NETs. Inhibition of LL37 reduced the NETs released from neutrophils. Conclusions: Taken together, the results of these studies suggest that dysfunction of telomeres may promote SVV through the mechanism of LL37-dependent NETs. Thus, targeting the LL37-NETs may be a novel therapy for SVV.

1 June 2025 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
RKRachel Kohn
Rachel Kohn
CKCraig Kwiatkowski
Craig Kwiatkowski
YLYingying Lu
Yingying Lu
TPTaara V. Prasad
Taara V. Prasad
EDErich Dress
Erich Dress
RHRachel A. Hadler
Rachel A. Hadler

19 August 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
MLMatthieu Legrand
Matthieu Legrand
HNHanh Nguyen
Hanh Nguyen
CCCarolyn S. Calfee
Carolyn S. Calfee
YLYingying Lu
Yingying Lu
MHMichael Harhay
Michael Harhay
APAlexendar R. Perez
Alexendar R. Perez
Sepsis is the leading cause of acute kidney injury in critically ill patients, and this complication carries a high risk of death. The biology underlying it varies between patients, which may explain why treatments have not succeeded. Here we show, using an ensemble method that groups patients by patterns across hundreds of blood proteins in three independent groups of patients, that sepsis-associated acute kidney injury comprises two reproducible subphenotypes. One subphenotype shows widespread activation of inflammation, metabolism, and oxidative stress; the other shows a quieter profile. Patients in the inflammatory subtype have higher mortality, more complications, and fewer days alive and out of the intensive care unit. A simple seven-protein test reproduces these groupings and identifies them accurately in separate cohorts. In a randomized trial, the drug ilofotase alfa appears to benefit the inflammatory subtype but not the other, suggesting that this classification could guide future treatment.

29 July 2026 in Health Services Research
Verified
Journal Article
Open access
PDF file
CCChristopher F Chesley
Christopher F Chesley
YLYingying Lu
Yingying Lu
RKRachel Kohn
Rachel Kohn
HGHayley B. Gershengorn
Hayley B. Gershengorn
KVKelly C. Vranas
Kelly C. Vranas
MKMeeta Kerlin
Meeta Kerlin
Objective: Expanding on previous research applying value‐added modeling to clinician performance measurement, we quantified simultaneous nurse and physician performance among mechanically ventilated patients. Study Setting and Design: In a retrospective cohort spanning five academic hospitals, we used multiple linear regression to determine relationships between nurse and physician assignments and changes in patient illness severity (Laboratory‐based Acute Physiology Score) during intensive care unit (ICU) admission. Individual clinician performance was derived from regression coefficients. Collective clinician contribution to disease severity variance was assessed by comparing the coefficient of determination across clinician‐only and joint‐clinician models. Consistency of clinician performance estimates was cross‐validated using random 1:1 partitions of the patient population using Pearson's correlation. Data Sources and Analytic Sample: Electronic health record data were extracted from mechanically ventilated patients at study ICUs between 2018 and 2022. Principal Findings: Among 17,082 clinical encounters, 215 physicians, and 1719 nurses, nurse and physician assignments improved model fit. Together, they attributed 7% of variability in disease severity trajectory; separately, nurse assignments accounted for greater variance than physician assignments (6% vs. 4%, respectively). Cross‐partition clinician performance was moderately correlated ( r = 0.31 [nurses] , r = 0.4 [physicians], p < 0.001 for both comparisons). Conclusions: Individual nurse and physician care independently contribute to disease severity trajectory among mechanically ventilated patients.